about
Oxicams, a class of nonsteroidal anti-inflammatory drugs and beyondComplexes of the outer mitochondrial membrane protein mitoNEET with resveratrol-3-sulfateSubstrate-Selective Inhibition of Cyclooxygenase-2: Development and Evaluation of Achiral Profen ProbesExploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxibOxicams Bind in a Novel Mode to the Cyclooxygenase Active Site via a Two-water-mediated H-bonding NetworkCrystal structure of 12-lipoxygenase catalytic-domain-inhibitor complex identifies a substrate-binding channel for catalysisConservative Secondary Shell Substitution In Cyclooxygenase-2 Reduces Inhibition by Indomethacin Amides and Esters via Altered Enzyme Dynamics.13-Methylarachidonic acid is a positive allosteric modulator of endocannabinoid oxygenation by cyclooxygenase.Targeted imaging of cancer by fluorocoxib C, a near-infrared cyclooxygenase-2 probeAction at a distance: mutations of peripheral residues transform rapid reversible inhibitors to slow, tight binders of cyclooxygenase-2.Antitumor Activity of Cytotoxic Cyclooxygenase-2 Inhibitorsnido-Dicarbaborate Induces Potent and Selective Inhibition of Cyclooxygenase-2EPR spectroscopy and electrospray ionization mass spectrometry reveal distinctive features of the iron site in leukocyte 12-lipoxygenase.Cytotoxic cytochalasin metabolites of endophytic Endothia gyrosa.Covalent Modification of CDK2 by 4-Hydroxynonenal as a Mechanism of Inhibition of Cell Cycle Progression.Dual cyclooxygenase-fatty acid amide hydrolase inhibitor exploits novel binding interactions in the cyclooxygenase active site.Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors.(R)-N-(1-Methyl-2-hydroxyethyl)-13-(S)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing EnzymesFluorescent indomethacin-dansyl conjugates utilize the membrane-binding domain of cyclooxygenase-2 to block the opening to the active site
P50
Q27022351-5CF42450-571F-4D8E-BC6A-8D0D94AA1167Q27667884-2F4218CF-1B4E-4A94-B534-5519D8F5BF25Q27673277-88A86719-531A-4B72-AC3E-E060197AEC6DQ27680024-4FA19022-DF84-40C6-943C-2D12886EAE1DQ27681344-7E834604-385A-4DBA-B4B3-318B8044C2E3Q27681754-16B2D3A3-30C7-41D2-B5EA-20D491819139Q30699848-F296A33C-E72B-498D-8AE2-5E697D2C00EAQ35199462-03EFA64A-1C1E-4663-B0E3-3729767F3D56Q35602497-4C5244E7-AD73-4D88-9BCB-6D1A08F61890Q35608133-B2D20F49-DAEB-4278-B55F-99FD60113DB8Q36121287-7C9DC8E1-22B6-4AD1-AF99-2EDA85221245Q36987287-DAEC84AE-86CE-42FE-966F-FCA696C62A92Q37423449-A1B2D847-5E0E-405A-9E3E-C7F114D07050Q39845540-6EE1177B-9638-43FE-B536-A5E82D1B8980Q39972865-DD3BE862-982D-47ED-BAEE-3723375B045FQ48540880-19639742-3850-45CC-82E6-0FEAE376A50BQ50334520-E1204B01-10BC-4178-8B18-6E5A8449B504Q60722014-82705613-9AC2-4D35-95B9-850D02FA79BEQ89997761-43262411-0483-4E63-85C1-425418F9A462
P50
description
researcher ORCID: 0000-0002-6876-7991
@en
name
Shu Xu
@ast
Shu Xu
@en
Shu Xu
@es
Shu Xu
@nl
Shu Xu
@sl
type
label
Shu Xu
@ast
Shu Xu
@en
Shu Xu
@es
Shu Xu
@nl
Shu Xu
@sl
prefLabel
Shu Xu
@ast
Shu Xu
@en
Shu Xu
@es
Shu Xu
@nl
Shu Xu
@sl
P106
P1153
35197366800
P31
P496
0000-0002-6876-7991